Trials / Completed
CompletedNCT00186251
High Dose Chemotherapy Followed By PBSC Rescue for HD
Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (planned)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 4 Weeks – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the role of high dose chemotherapy with autologous hematopoietic cell transplantation in the treatment of Hodgkin's Disease.
Detailed description
Use of High Dose Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Relapsed or Resistant Hodgkin's Disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | high dose chemo then auto hematopoietic cell transplant |
Timeline
- Start date
- 1998-03-01
- Completion
- 2005-07-01
- First posted
- 2005-09-16
- Last updated
- 2012-11-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00186251. Inclusion in this directory is not an endorsement.